Authors:
Kroger, N
Zabelina, T
Kruger, W
Renges, H
Stute, N
Durken, M
von Finkenstein, FG
Erttmann, R
Kabisch, H
Schafhausen, P
Jaburg, N
Loliger, C
Zander, AR
Citation: N. Kroger et al., Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors, ANN HEMATOL, 80(4), 2001, pp. 209-215
Authors:
Kroger, N
Zabelina, T
Sonnenberg, S
Kruger, W
Renges, H
Stute, N
Finkenstein, F
Mayer, U
Holstein, K
Fiedler, W
Colberg, H
Sonnen, R
Kuse, R
Braumann, D
Metzner, B
del Valle, F
Erttmann, R
Kabisch, H
Zander, AR
Citation: N. Kroger et al., Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia, BONE MAR TR, 26(7), 2000, pp. 711-716
Authors:
Schilling, FH
Berthold, F
Erttmann, R
Michaelis, J
Spix, C
Sander, J
Schwarz, K
Treuner, J
Citation: Fh. Schilling et al., Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: Interim results, MED PED ONC, 35(6), 2000, pp. 701-704
Authors:
Kroger, N
Zeller, W
Hassan, HT
Kruger, W
Renges, H
Russmann, B
Fuchs, N
Rauhoft, C
Gutensohn, K
Loliger, C
Erttmann, R
Kuhnl, P
Zander, AR
Citation: N. Kroger et al., Steady-state mobilization of peripheral blood progenitor cells by cytokines alone in patients with solid tumors or hematological malignancies, INFUSIONSTH, 26(2), 1999, pp. 85-90
Authors:
Fuchs, J
Bode, U
von Schweinitz, D
Weinel, P
Erttmann, R
Harms, D
Mildenberger, D
Citation: J. Fuchs et al., Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma:A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HE 94, KLIN PADIAT, 211(4), 1999, pp. 305-309
Authors:
Schmitt, C
David, K
Hiller, J
Schrum, J
Bredehorst, R
Vogel, CW
Loliger, C
Erttmann, R
Citation: C. Schmitt et al., Natural human IgM antibodies in neuroblastoma therapy: Preliminary resultsfrom a phase I/II therapy study, KLIN PADIAT, 211(4), 1999, pp. 314-318
Authors:
Zander, AR
Zabelina, T
Kroger, N
Renges, H
Kruger, W
Loliger, C
Durken, M
Stockschlader, M
de Wit, M
Wacker-Backhaus, G
Bielack, S
Jaburg, N
Russmann, B
Erttmann, R
Kabisch, H
Citation: Ar. Zander et al., Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, BONE MAR TR, 23(9), 1999, pp. 889-893
Authors:
Kruger, W
Russmann, B
Kroger, N
Salomon, C
Ekopf, N
Elsner, HA
Kaulfers, PM
Mack, D
Fuchs, N
Durken, M
Kabisch, H
Erttmann, R
Zander, AR
Citation: W. Kruger et al., Early infections in patients undergoing bone marrow or blood stem cell transplantation - a 7 year single centre investigation of 409 cases, BONE MAR TR, 23(6), 1999, pp. 589-597
Authors:
David, K
Ollert, MW
Vollmert, C
Heiligtag, S
Eickhoff, B
Erttmann, R
Bredehorst, R
Vogel, CW
Citation: K. David et al., Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a M-r 260,000 antigen, CANCER RES, 59(15), 1999, pp. 3768-3775
Authors:
Durken, M
Horstmann, M
Bieling, P
Erttmann, R
Kabisch, H
Loliger, C
Schneider, EM
Hellwege, HH
Kruger, W
Kroger, N
Citation: M. Durken et al., Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients, BR J HAEM, 106(4), 1999, pp. 1052-1058
Authors:
Kroger, N
Kruger, W
Wacker-Backhaus, G
Hegewisch-Becker, S
Stockschlader, M
Fuchs, N
Russmann, B
Renges, H
Durken, M
Bielack, S
de Wit, M
Schuch, G
Bartels, H
Braumann, D
Kuse, R
Kabisch, H
Erttmann, R
Zander, AR
Citation: N. Kroger et al., Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia, BONE MAR TR, 22(11), 1998, pp. 1029-1033